302 related articles for article (PubMed ID: 30087005)
21. Current concepts of ethanol dependence.
Littleton J; Little H
Addiction; 1994 Nov; 89(11):1397-412. PubMed ID: 7841849
[TBL] [Abstract][Full Text] [Related]
22. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
Corti S; Faravelli I; Cardano M; Conti L
Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
[TBL] [Abstract][Full Text] [Related]
23. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
[TBL] [Abstract][Full Text] [Related]
24. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
[TBL] [Abstract][Full Text] [Related]
25. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
26. iPS cell derived neuronal cells for drug discovery.
Heilker R; Traub S; Reinhardt P; Schöler HR; Sterneckert J
Trends Pharmacol Sci; 2014 Oct; 35(10):510-9. PubMed ID: 25096281
[TBL] [Abstract][Full Text] [Related]
27. Alcohol dependence: a commentary on mechanisms.
Hoffman PL; Tabakoff B
Alcohol Alcohol; 1996 Jul; 31(4):333-40. PubMed ID: 8879279
[TBL] [Abstract][Full Text] [Related]
28. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
[TBL] [Abstract][Full Text] [Related]
29. Neuronal differentiation defects in induced pluripotent stem cells derived from a Prader-Willi syndrome patient.
Soeda S; Saito R; Fujita N; Fukuta K; Taniura H
Neurosci Lett; 2019 Jun; 703():162-167. PubMed ID: 30902571
[TBL] [Abstract][Full Text] [Related]
30. Regeneration of the damaged central nervous system through reprogramming technology: basic concepts and potential application for cell replacement therapy.
Matsui T; Akamatsu W; Nakamura M; Okano H
Exp Neurol; 2014 Oct; 260():12-8. PubMed ID: 23036600
[TBL] [Abstract][Full Text] [Related]
31. Transcriptomics analysis of iPSC-derived neurons and modeling of neuropsychiatric disorders.
Lin M; Lachman HM; Zheng D
Mol Cell Neurosci; 2016 Jun; 73():32-42. PubMed ID: 26631648
[TBL] [Abstract][Full Text] [Related]
32. Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia.
Balan S; Toyoshima M; Yoshikawa T
Neurobiol Dis; 2019 Nov; 131():104162. PubMed ID: 29729395
[TBL] [Abstract][Full Text] [Related]
33. Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system.
Ribbe K; Ackermann V; Schwitulla J; Begemann M; Papiol S; Grube S; Sperling S; Friedrichs H; Jahn O; Sillaber I; Gefeller O; Krampe H; Ehrenreich H
Arch Gen Psychiatry; 2011 Dec; 68(12):1247-56. PubMed ID: 21810631
[TBL] [Abstract][Full Text] [Related]
34. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
Iglesias-García O; Pelacho B; Prósper F
J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
[TBL] [Abstract][Full Text] [Related]
35. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
[TBL] [Abstract][Full Text] [Related]
36. A Novel Protocol to Differentiate Induced Pluripotent Stem Cells by Neuronal microRNAs to Provide a Suitable Cellular Model.
Zare M; Soleimani M; Akbarzadeh A; Bakhshandeh B; Aghaee-Bakhtiari SH; Zarghami N
Chem Biol Drug Des; 2015 Aug; 86(2):232-8. PubMed ID: 25430972
[TBL] [Abstract][Full Text] [Related]
37. [Modeling neurological and psychiatric disorders in vitro using induced pluripotent stem cells: highlighting findings in Alzheimer's disease and schizophrenia].
Hathy E; Kalman S; Apati A; Nemoda Z; Rethelyi JM
Neuropsychopharmacol Hung; 2016 Dec; 18(4):188-198. PubMed ID: 28259862
[TBL] [Abstract][Full Text] [Related]
38. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
39. Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases.
Adegbola A; Bury LA; Fu C; Zhang M; Wynshaw-Boris A
Stem Cells Transl Med; 2017 Dec; 6(12):2062-2070. PubMed ID: 29027744
[TBL] [Abstract][Full Text] [Related]
40. Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.
Liu L; Huang JS; Han C; Zhang GX; Xu XY; Shen Y; Li J; Jiang HY; Lin ZC; Xiong N; Wang T
Mol Neurobiol; 2016 Dec; 53(10):6698-6708. PubMed ID: 26659595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
